Thank you for considering participation in our research study on the assessment of oncology pharmacy education in Saudi Arabian colleges of pharmacy. This study comes at a time when the field of oncology treatment is undergoing rapid advancements, necessitating a parallel evolution in the role and education of oncology pharmacists.
- In Saudi Arabia, a country experiencing significant growth in healthcare services, it is increasingly crucial to align pharmacy education with these advancements. Oncology pharmacists play a vital role that goes beyond traditional medication dispensing. They are key in educating patients, especially about oral medications, managing symptoms, and collaborating as part of multidisciplinary teams to provide comprehensive cancer care.
- This study's primary aim is to evaluate the current state of oncology pharmacy education in Saudi Arabian colleges of pharmacy, identify gaps in the current curriculum and educational practices, and gather insights from various stakeholders, including students, faculty, and practicing pharmacists, regarding the effectiveness and relevance of current oncology pharmacy education. We will be collecting both quantitative data through this survey to identify significant patterns and gain a deeper understanding of participants' perceptions and experiences.
- If you have any questions about this survey, please feel free to contact us [email protected]
- Participation in this survey is completely voluntary, and you are free to choose not to participate by simply not filling out the survey or to withdraw at any time without any consequences.
- We greatly appreciate your valuable contribution and the time you dedicate to this study.
1. Participants' characteristics
1. Age (years) o Open answers
2. Nationality o Saudi o Not Saudi
3. Gender o Male o Female
4. college
o King Saud University
o Princess Nourah Bint Abdulrahman University Imam o Umm Al-Qura University
o King Abdulaziz University
o Ibn Sina National College for Medical Studies
o King Saud Bin Abdulaziz University for Health Sciences o Almaarefa University
o Jazan University
o Prince Sattam Bin Abdulaziz University o Qassim University
o Taibah University o Alfaisal University o Almaareffa University o King Khalid University o King Faisal University
o Imam Abdulrahman Bin Faisal University o Al Jouf University
o King Saud Bin Abdulaziz University for Healrh Sciences o Shaqra University
o Northern Borders University o University Of Tabuk
o Najran University o Albaha University
o Batterjee Medical College
o Fakeeh College For Medical Sciences o Dar Al Uloom University
o Dammam University o Riyadh Elm University o Buraydah University
o Mohammed Al-Mana College for Medical Sciences
2. Course information 5.
Oncology topics that are covered for students in the
pharmacotherapy course (check all that apply)
o Supportive care I (pain, nausea, vomiting, constipation, diarrhea, fatigue, mucositis)
o Breast cancer o Cervical cancer o Colorectal cancer o Renal cell carcinoma o Leukemias, acute o Leukemias, chronic o Lung cancer
o Lymphomas (Hodgkin’s lymphoma, non-Hodgkin’s lymphoma)
o Melanoma
o Myelodysplastic syndromes
o Oncologic emergencies (e.g., tumor lysis syndrome, hypercalcemia, coagulopathy, superior vena cava syndrome)
o Ovarian cancer
o Plasma cell disorders (e.g., multiple myeloma) o Prostate cancer
o Supportive care II (e.g., myelosuppression, thrombosis, extravasation)
o Bladder cancer o Endometrial cancer
o Germ cell tumors (e.g., testicular cancer)
o Head and neck cancer
o Hematopoietic stem cell transplantation o Gastrointestinal cancers, other (e.g., carcinoid,
esophageal, gastric, hepatobiliary, pancreatic) o Mesothelioma
Myeloproliferative disorders (e.g., polycythemia vera, myelofibrosis)
o Pediatric malignancies (e.g., Ewing sarcoma, Wilms tumor, osteosarcoma, rhabdomyosarcoma)
o Skin cancer, nonmelanoma (e.g., basal cell carcinoma, cutaneous squamous cell carcinoma)
o Thyroid cancer
6.
Education and experience of instructions teaching oncology pharmacotherapy
o BCOP-certified full or shared faculty members o Full or shared faculty members who are not BCOP-
certified.
o Adjunct faculty or guest lecturers employed by an affiliated health system d. Faculty who do not practice or specialize in oncology.
o Physicians
o Other (Open field)
7. Teaching methods used for oncology pharmacotherapy
o Traditional live lecture o Small group discussions o Case studies
o Patient care laboratory o Self-paced modules
o Electronic teaching methods
8. Placement of oncology
pharmacotherapy in the curriculum
o Longitudinally, throughout the curriculum o Second year
o Third year o Fourth year o Fifth year o Not applying 9.
How are oncology pathophysiology and
pharmacotherapy taught in your pharmacy school?
o Together in a single course
o Pathophysiology taught in the year or semester before pharmacotherapy
o Pathophysiology taught concurrently with
pharmacotherapy, but in a separate course d. Online pathophysiology and pharmacotherapy course(s) o Together as part of an oncology module in a systems-
oriented integrated curriculum
10.
Is there an oncology
pharmacotherapy elective course? o Yes o No
11.
Are there any other subjects where oncology is included in its teaching such as (pharmacogenomics, medicinal chemistry,….) ?
o Yes o No
o If yes, Mention it here (open answers)
12.
Are there any other activities related to oncology during the years of study?
o Yes o No
o If yes, Mention it here (open answers)
3. Opinion section
13.
I think my school should dedicate more time to oncology
pharmacotherapy
o Strongly Disagree o Disagree
o Neutral o Agree
o Strongly Agree 14.
Instructors who teach oncology pharmacotherapy at my school are well qualified to do so.
o Strongly Disagree o Disagree
o Neutral
o Agree
o Strongly Agree
15.
The students are very enthusiastic and entertained during the oncology course
o Strongly Disagree o Disagree
o Neutral o Agree
o Strongly Agree
16. Students' grades are high in the oncology course
o Strongly Disagree o Disagree
o Neutral o Agree
o Strongly Agree
17.
Additional comments
o Open answers
